OMB
.report
Search
FDA 2252 Transmittal of annual drug and biologic report under 314
Applications for FDA Approval to Market a New Drug
FDA 2252 reports rev 2021
Subpart B - Applications
OMB: 0910-0001
OMB.report
HHS/FDA
OMB 0910-0001
ICR 202402-0910-003
IC 5662
FDA 2252 Transmittal of annual drug and biologic report under 314
( )
⚠️ Notice: This form may be outdated. More recent filings and information on OMB 0910-0001 can be found here:
2024-12-26 - Revision of a currently approved collection
Document [file]
Download:
file
|
pdf
File Type
inode/x-empty
© 2025 OMB.report |
Privacy Policy